Speech-Language Pathologists in White Lake, MI Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Mrs. Kristine Ann Krajewski, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 696 Akehurst Ln, White Lake, MI 48386 Phone: 248-345-7983

Andrew Patrick Tippen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 935 Union Lake Rd, White Lake, MI 48386 Phone: 248-360-7235

Susan Lynn Ingram, MA, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8182 Sequoia Ln, White Lake, MI 48386 Phone: 248-807-1042

Speakbeak Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4687 Fox Chase Dr, White Lake, MI 48383 Phone: 248-701-3129

Nerissa Sukarukoff, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9274 Steephollow Drive, White Lake, MI 48386 Phone: 313-410-0471

Leah King Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8726 Sandycrest Dr, White Lake, MI 48386 Phone: 248-698-3289

Intrepid Therapy Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9274 Steephollow Dr, White Lake, MI 48386 Phone: 313-410-0471

Courtney Page, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8119 Sutton Ct, White Lake, MI 48386 Phone: 586-876-9059

News Archive

Parent misconceptions about child organ donation may complicate the process

Children in need of an organ transplant often wait longer than adults for available organs, as in many cases, they require organ donations from another child of a similar age or size.

Advaxis' 'Prokaryotic peptides for enhancing antigen immunogenicity' European patent application allowed

Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has been notified by the European Patent Office that patent application WO2001/072329, for the use of Prokaryotic PEST-Like Peptides for Enhancing Immunogenicity of Antigen has been allowed for issuance. This patent will be #1,303,299 when granted, and will be licensed exclusively to Advaxis by the University of Pennsylvania.

HealthSpring announces acquisition of Bravo Health

HealthSpring, Inc. today announced that it has entered into a definitive agreement to acquire all of the outstanding capital stock of Bravo Health, Inc., an operator of Medicare Advantage coordinated care plans in Pennsylvania, the Mid-Atlantic region, and Texas, and Medicare Part D stand-alone prescription drug plans in 43 states.

Alliant Health Plans forges alliance with Alliant Sense

Alliant Health Plans, a not-for-profit health plan with a radically new approach focused on patient care, and Global Behavioral Solutions (gBehavior), the industry leader in the utilization of incentive-based behavior modification strategies, have formed an alliance to launch Alliant Sense, a wellness rewards program that motivates members and patients to make healthy life choices.

Gilenya - pill for relapsing-remitting multiple sclerosis recommended by NICE

The National Institute for Health and Clinical Excellence (Nice) issued new draft guidance recommending fingolimod (brand name Gilenya) on the NHS for some patients with a form of MS. The new drug can help reduce the number of relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS), which is characterized by periods when symptoms worsen and then improve.

Read more Medical News

› Verified 1 days ago